Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makito Tanabe

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Diabetology & Metabolic Syndrome|May 22, 2015
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysisYuichi Terawaki, Takashi Nomiyama, Hiroyuki Takahashi, et al.
Heliyon|November 18, 2020
Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat dietTsuyoshi Horikawa, Takako Kawanami, Yuriko Hamaguchi, et al.
Atherosclerosis|November 15, 2008
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndromeKazuhiko Kotani, Noriko Satoh, Yasuhisa Kato, et al.
Diabetology International|August 18, 2020
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)Yuichi Terawaki, Chikayo Iwaya, Takashi Nomiyama, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2012
Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' diseaseTetsuya Tagami, Yuko Yambe, Tsuyoshi Tanaka, et al.
Journal of Diabetes Investigation|March 9, 2020
Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progressionToru Shigeoka, Takashi Nomiyama, Takako Kawanami, et al.
Endocrine Journal|November 29, 2019
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferationShiho Komatsu, Takashi Nomiyama, Tomohiro Numata, et al.
Endocrinology|October 19, 2017
Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB ActivationChikayo Iwaya, Takashi Nomiyama, Shiho Komatsu, et al.
Diabetes|June 1, 2014
Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growthTakashi Nomiyama, Takako Kawanami, Shinichiro Irie, et al.
Auris, Nasus, Larynx|July 30, 2024
Summary of Japanese clinical practice guidelines for Bell's palsy (idiopathic facial palsy) - 2023 update edited by the Japan Society of Facial Nerve ResearchTakashi Fujiwara, Naohito Hato, Takashi Kasahara, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Diabetology & Metabolic Syndrome|May 22, 2015
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysisYuichi Terawaki, Takashi Nomiyama, Hiroyuki Takahashi, et al.
Heliyon|November 18, 2020
Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat dietTsuyoshi Horikawa, Takako Kawanami, Yuriko Hamaguchi, et al.
Atherosclerosis|November 15, 2008
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndromeKazuhiko Kotani, Noriko Satoh, Yasuhisa Kato, et al.
Diabetology International|August 18, 2020
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)Yuichi Terawaki, Chikayo Iwaya, Takashi Nomiyama, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2012
Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' diseaseTetsuya Tagami, Yuko Yambe, Tsuyoshi Tanaka, et al.
Journal of Diabetes Investigation|March 9, 2020
Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progressionToru Shigeoka, Takashi Nomiyama, Takako Kawanami, et al.
Endocrine Journal|November 29, 2019
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferationShiho Komatsu, Takashi Nomiyama, Tomohiro Numata, et al.
Endocrinology|October 19, 2017
Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB ActivationChikayo Iwaya, Takashi Nomiyama, Shiho Komatsu, et al.
Diabetes|June 1, 2014
Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growthTakashi Nomiyama, Takako Kawanami, Shinichiro Irie, et al.
Auris, Nasus, Larynx|July 30, 2024
Summary of Japanese clinical practice guidelines for Bell's palsy (idiopathic facial palsy) - 2023 update edited by the Japan Society of Facial Nerve ResearchTakashi Fujiwara, Naohito Hato, Takashi Kasahara, et al.
Pageof 5